Search - tctmd.com

Displaying 341 - 360 of 496

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Philipp Blanke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Presenter: Ashish Pershad, Roberto Spina, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Is Paravalvular Regurgitation After TAVR Still an Important Consideration in 2018?

Presenter: Philippe Pibarot

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #3: A Small (Undersized) Surgical Bioprosthesis

Presenter: Michael J. Reardon, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Presenter: Amar Krishnaswamy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Transcaval TAVR Complicated by Double Wammy

Presenter: Ashish Pershad, Waleed Alharbi, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Presenter: Brian K. Whisenant, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Presenter: Fabian Nietlispach

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #1: A Poorly Visible Surgical Bioprosthesis

Presenter: Isaac George, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Unexpected Apparition - or - Old Valves Die Hard

Presenter: Ashish Pershad, Takehiro Yamashita, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Rare Cause of Stroke After TAVR: Foreign Body

Presenter: Ashish Pershad, Abhishek Bhagat, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks

Presenter: James B. Hermiller Jr

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

What a NEAR MISS! Aortic Sinus to RV Fistula Post-TAVR Treated With Percutaneous Closure - Be Careful When Postdilating!

Presenter: Ashish Pershad, William Merhi, MD

June 21, 2018

Advertisement

NO: The Data Are Weak and the Costs Are Prohibitive!

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

YES: Review of ALL the Data and Common Sense Tell the Story!

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Is Paravalvular Regurgitation After TAVR Still an Important Consideration in 2018?

Case #3: A Small (Undersized) Surgical Bioprosthesis

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Transcaval TAVR Complicated by Double Wammy

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Case #1: A Poorly Visible Surgical Bioprosthesis

An Unexpected Apparition - or - Old Valves Die Hard

Cedars-Sinai Medical Center (USA)

A Rare Cause of Stroke After TAVR: Foreign Body

A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Erasmus University (The Netherlands)

What a NEAR MISS! Aortic Sinus to RV Fistula Post-TAVR Treated With Percutaneous Closure - Be Careful When Postdilating!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content